255 related articles for article (PubMed ID: 36511140)
1. Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy.
Mitra S; Chen B; Wang P; Chown EE; Dear M; Guisso DR; Mariam U; Wu J; Gumusgoz E; Minassian BA
Dis Model Mech; 2023 Jan; 16(1):. PubMed ID: 36511140
[TBL] [Abstract][Full Text] [Related]
2. Impaired malin expression and interaction with partner proteins in Lafora disease.
Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ
J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
Nitschke S; Sullivan MA; Mitra S; Marchioni CR; Lee JPY; Smith BH; Ahonen S; Wu J; Chown EE; Wang P; Petković S; Zhao X; DiGiovanni LF; Perri AM; Israelian L; Grossman TR; Kordasiewicz H; Vilaplana F; Iwai K; Nitschke F; Minassian BA
Brain; 2022 Jul; 145(7):2361-2377. PubMed ID: 35084461
[TBL] [Abstract][Full Text] [Related]
4. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.
DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ
J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597
[TBL] [Abstract][Full Text] [Related]
5. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA
J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944
[TBL] [Abstract][Full Text] [Related]
6. Lafora disease: Current biology and therapeutic approaches.
Mitra S; Gumusgoz E; Minassian BA
Rev Neurol (Paris); 2022 Apr; 178(4):315-325. PubMed ID: 34301405
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
Romá-Mateo C; Sanz P; Gentry MS
IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
[TBL] [Abstract][Full Text] [Related]
8. Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells.
Zeng L; Wang Y; Baba O; Zheng P; Liu Y; Liu Y
FEBS J; 2012 Jul; 279(14):2467-78. PubMed ID: 22578008
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.
Sanchez-Martin P; Lahuerta M; Viana R; Knecht E; Sanz P
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118613. PubMed ID: 31758957
[TBL] [Abstract][Full Text] [Related]
10. Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism.
Couarch P; Vernia S; Gourfinkel-An I; Lesca G; Gataullina S; Fedirko E; Trouillard O; Depienne C; Dulac O; Steschenko D; Leguern E; Sanz P; Baulac S
J Mol Med (Berl); 2011 Sep; 89(9):915-25. PubMed ID: 21505799
[TBL] [Abstract][Full Text] [Related]
11. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway.
Upadhyay M; Gupta S; Bhadauriya P; Ganesh S
Biochem Biophys Res Commun; 2015 Aug; 464(1):106-11. PubMed ID: 26102034
[TBL] [Abstract][Full Text] [Related]
12. Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase.
Liu Y; Zeng L; Ma K; Baba O; Zheng P; Liu Y; Wang Y
Mol Neurobiol; 2014 Apr; 49(2):645-57. PubMed ID: 24068615
[TBL] [Abstract][Full Text] [Related]
13. Loss of laforin or malin results in increased Drp1 level and concomitant mitochondrial fragmentation in Lafora disease mouse models.
Upadhyay M; Agarwal S; Bhadauriya P; Ganesh S
Neurobiol Dis; 2017 Apr; 100():39-51. PubMed ID: 28063983
[TBL] [Abstract][Full Text] [Related]
14. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA
EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304
[TBL] [Abstract][Full Text] [Related]
15. Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin.
Vernia S; Rubio T; Heredia M; Rodríguez de Córdoba S; Sanz P
PLoS One; 2009 Jun; 4(6):e5907. PubMed ID: 19529779
[TBL] [Abstract][Full Text] [Related]
16. Advances in lafora progressive myoclonus epilepsy.
Delgado-Escueta AV
Curr Neurol Neurosci Rep; 2007 Sep; 7(5):428-33. PubMed ID: 17764634
[TBL] [Abstract][Full Text] [Related]
17. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?
Puri R; Ganesh S
Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S
Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386
[TBL] [Abstract][Full Text] [Related]
19. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.
Gentry MS; Worby CA; Dixon JE
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8501-6. PubMed ID: 15930137
[TBL] [Abstract][Full Text] [Related]
20. Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).
Worby CA; Gentry MS; Dixon JE
J Biol Chem; 2008 Feb; 283(7):4069-76. PubMed ID: 18070875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
